Document is current
Any future updates will be listed below
-
Authors
Murray, Benjamin O. https://orcid.org/0000-0002-9095-366X
Gao, Jinhui
Pasquina-Lemonche, Laia
Swarbrick, Katherine
Simpson, Guy
Chambers, Mark A.
Pandha, Hardev
Freeman, Alex
Rohn, Jennifer L.
-
Funding
Funding for this research was provided by:
RCUK | Engineering and Physical Sciences Research Council (UCL Doctoral Training Programme)
RCUK | Engineering and Physical Sciences Research Council (UCL Doctoral Training Programme)
Rosetrees Trust (Seedcorn2020\100019)
Rosetrees Trust (CF-2022-2\124)
Rosetrees Trust (Seedcorn2020\100019 and CF-2022-2\124)
UCL Therapeutic Innovation Networks AtoCap Ltd.
Wellcome Trust (227581/Z/23/Z)
- License Information
-
More Information
Article History
Received: 21 July 2025
Revised: 20 March 2026
Accepted: 13 May 2026
First Online: 2 June 2026
Competing interests
: JLR holds stock options in AtoCap, a UCL spinout company seeking novel cures for urological disorders; no therapy currently being investigated by this company is used or mentioned in this paper. All other authors declare that they have no competing interests.
